Avalyn Pharma (AVLN) Rises 1.95% Amid Volatile Market; Pipeline & Earnings Outlook
Explore Avalyn Pharma’s latest market snapshot—$27.25/share, 1.95% 24‑hr rise, 200‑day SMA above current price, and pipeline prospects driving a potential rebound.
- AVALYN PHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read